File image: Dr Huzaifa Khorakiwala, Govt Director, Wockhardt Ltd
Dr Huzaifa Khorakiwala, Govt Director of Wockhardt Ltd, on Saturday mentioned the imposition of US reciprocal tariffs, if prolonged to Indian pharmaceutical merchandise, will pose a major problem to the trade. “If tariffs come, it isn’t a possibility; it’s a problem, and it’s the way you deal with the problem that’s the query,” he mentioned.
US President Donald Trump’s reciprocal tariff announcement final week has been sending tremors globally, together with in India. Nevertheless, in current developments, Trump introduced on Wednesday a 90-day pause on tariffs in opposition to all international locations besides China for negotiating tariffs. He has additionally mentioned the US will quickly announce main tariffs on pharma merchandise. Going additional, Khorakiwala mentioned Wockhardt Ltd has change into the world chief in antibiotic analysis, with trials accepted.
“Trials are accepted now, and we have gotten the world chief in antibiotic analysis, and blockbuster product WCK-5222-ZENIC has given a 97 per cent success within the phase-3 scientific trial, and we’re assured it’ll save 5 million lives yearly resulting from antimicrobial resistance. It is without doubt one of the best breakthroughs in medication because the discovery of penicillin by Alexander,” he mentioned.
In response to official information of the Ministry of Chemical substances and Fertilizers, India’s pharmaceutical trade has gained worldwide recognition because the ‘Pharmacy of the World,’ significantly for its position in supplying vaccines, important medicines, and medical provides in the course of the Covid-19 pandemic and past. The sector has showcased its revolutionary capabilities and established itself as a vital international pharmaceutical worth chain member.
Rating third globally in drug and pharmaceutical manufacturing by quantity, India exports to roughly 200 international locations and territories. The highest 5 locations for these exports are the US, Belgium, South Africa, the UK, and Brazil.
Revealed on April 12, 2025